| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |